Patent Assignment
Reel/Frame 025051/0924
Change of Name
Recorded: 2010-09-29
Pages: 8
Assignor
SHIRE HOLDINGS AG
Executed: 2010-01-02
Assignee
SHIRE BIOPHARMACEUTICALS HOLDINGS IRELAND LIMITED
22 GRENVILLE STREET, ST. HELIER, JE4 8PX, JERSEY
Covered Properties
(4)
Treatment of Bone Diseases
Formulation and methods for the treatment of thrombocythemia
Application:
10/762,566 →
Publication:
US 2004/0209907
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
Application:
11/197,774 →
Publication:
US 2006/0030574
Quinazoline Derivatives and Their Use in the Treatment of Thrombocythemia
Application:
12/580,661 →
Publication:
US 2010/0093772
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 16, 2001
From: ATHERTON, NIGEL D.; TOTTEN, JOSEPH W.; GAITONDE, MICHAEL D.
To: SHIRE HOLDINGS AG
Reel/Frame 012310/0341 →
Assignment of Assignor's Interest
Jun 23, 2004
From: FRANKLIN, RICHARD
To: SHIRE HOLDING AG
Reel/Frame 015493/0398 →
Assignment of Assignor's Interest
Oct 21, 2005
From: FRANKLIN, RICHARD
To: SHIRE HOLDINGS AG
Reel/Frame 017133/0135 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 015493 Frame 0398. Assignor(S) Hereby Confirms the Corrected Name of the Assignee.
Aug 21, 2006
From: FRANKLIN, RICHARD
To: SHIRE HOLDINGS AG
Reel/Frame 018189/0131 →
Assignment of Assignor's Interest
Sep 30, 2010
From: FRANKLIN, RICHARD
To: SHIRE HOLDINGS AG
Reel/Frame 025070/0146 →
Change of Name
Oct 8, 2010
From: SHIRE HOLDINGS AG
To: SHIRE BIOPHARMACEUTICALS HOLDINGS IRELAND LIMITED
Reel/Frame 025112/0931 →